The co-chaperone XAP2 is required for activation of hypothalamic thyrotropin-releasing hormone transcription in vivo

Marie-Stephanie Clerget-Froidevaux, Petra Berg, Isabelle Seugnet, Stephanie S Decherf, Nathalie Becker, Laurent M Sachs, Patrice Bilesimo, Maria Nygard, Ingemar Pongratz, Barbara A Demeneix

Research output: Contribution to journalArticleResearchpeer-review

33 Citations (Scopus)


Transcriptional control of hypothalamic thyrotropin-releasing hormone (TRH) integrates central regulation of the hypothalamo-hypophyseal-thyroid axis and hence thyroid hormone (triiodothyronine (T(3))) homeostasis. The two beta thyroid hormone receptors, TRbeta1 and TRbeta2, contribute to T(3) feedback on TRH, with TRbeta1 having a more important role in the activation of TRH transcription. How TRbeta1 fulfils its role in activating TRH gene transcription is unknown. By using a yeast two-hybrid screening of a mouse hypothalamic complementary DNA library, we identified a novel partner for TRbeta1, hepatitis virus B X-associated protein 2 (XAP2), a protein first identified as a co-chaperone protein. TR-XAP2 interactions were TR isoform specific, being observed only with TRbeta1, and were enhanced by T(3) both in yeast and mammalian cells. Furthermore, small inhibitory RNA-mediated knockdown of XAP2 in vitro affected the stability of TRbeta1. In vivo, siXAP2 abrogated specifically TRbeta1-mediated (but not TRbeta2) activation of hypothalamic TRH transcription. This study provides the first in vivo demonstration of a regulatory, physiological role for XAP2.
Original languageEnglish
Pages (from-to)1035 - 1039
Number of pages5
JournalEMBO Reports
Issue number10
Publication statusPublished - 2006
Externally publishedYes

Cite this